Lupin has launched a generic version of Varenicline tablets, used for smoking cessation treatment, in the US market, after receiving approval from the USFDA. The product is the generic equivalent of PF Prism CV's Chantix tablets.
New Delhi, Jan 10 (PTI) Drug firm Lupin on Wednesday said it has launched a product, used as an aid to smoking cessation treatment, in the US market.
The company has launched Varenicline tablets in strengths of 0.5 mg and 1 mg, after having received approval from the US Food and Drug Administration (USFDA), the Mumbai-based drug maker said in a regulatory filing.
The company's product is the generic equivalent of PF Prism CV's Chantix tablets, it added.
It is indicated for use as an aid to smoking cessation treatment.
As per the IQVIA data, Varenicline tablets had estimated annual sales of USD 412 million in the US.
Shares of the company were trading 0.75 per cent up at Rs 1,406.50 apiece on the BSE.
Home » Market News » Lupin Launches Generic Smoking Cessation Drug in US
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback